Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01158729
Recruitment Status : Terminated (Grant funding expired, poor patient enrollment)
First Posted : July 8, 2010
Last Update Posted : January 20, 2014
Children's Research Institute
rEVO Biologics
Information provided by (Responsible Party):
Robert Niebler, Medical College of Wisconsin

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013